| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |